|
Sign In to gain access to subscriptions and/or personal tools.
|
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group
Background. In January 2002 the New York City Chapter of the National Multiple Sclerosis Society convened a panel of experts to review the issue of depressive affective disorders associated with multiple sclerosis (MS). This Consensus Conference was supported by a grant from the Goldman family of New York City. Results. The panel reviewed summaries of current epidemiologic, neurobiologic, and therapeutic studies having to do with depressive disorders among MS patient populations. Depressive disorders occur at high rates among patients with MS, and there is reason to believe that the immunopathology of the disease is involved in the clinical expression of affective disorders. The depressive syndromes of MS have a major, negative impact on quality of life for MS sufferers, but are treatable. At the present time, most MS patients with depression do not receive adequate recognition and treatment. Conclusions. The Goldman Consensus Conference Study Group provides recommendations for improved screening, diagnosis, and clinical management for depressive affective disorders among patients suffering from MS.
Key Words: affective disorders • cognition • depression • multiple sclerosis • neuropsychiatry
Multiple Sclerosis, Vol. 11, No. 3,
328-337 (2005)
DOI: 10.1191/1352458505ms1162oa
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
O.-P. Dahl, E. Stordal, S. Lydersen, and R. Midgard
Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trondelag County, Norway
Multiple Sclerosis,
December 1, 2009;
15(12):
1495 - 1501.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. Marrie, R Horwitz, G Cutter, T Tyry, D Campagnolo, and T Vollmer
The burden of mental comorbidity in multiple sclerosis: frequent, underdiagnosed, and undertreated
Multiple Sclerosis,
March 1, 2009;
15(3):
385 - 392.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. S. Haussleiter, M. Brune, and G. Juckel
Review: Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment
Therapeutic Advances in Neurological Disorders,
January 1, 2009;
2(1):
13 - 29.
[Abstract]
[PDF]
|
|
|
|
|
|
|
F Patti
Cognitive impairment in multiple sclerosis
Multiple Sclerosis,
January 1, 2009;
15(1):
2 - 8.
[Abstract]
[PDF]
|
|
|
|
|
|
|
G. Kraft, K. Johnson, K Yorkston, D Amtmann, A Bamer, C Bombardier, D Ehde, R Fraser, and H Starks
Setting the agenda for multiple sclerosis rehabilitation research
Multiple Sclerosis,
November 1, 2008;
14(9):
1292 - 1297.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Ehrensperger, A Grether, G Romer, M Berres, A. Monsch, L Kappos, and B Steck
Neuropsychological dysfunction, depression, physical disability, and coping processes in families with a parent affected by multiple sclerosis
Multiple Sclerosis,
September 1, 2008;
14(8):
1106 - 1112.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S Johansson, C Ytterberg, J Hillert, L W. Holmqvist, and L von Koch
A longitudinal study of variations in and predictors of fatigue in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
April 1, 2008;
79(4):
454 - 457.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Patten, J. Williams, and L. Metz
Anti-depressant use in association with interferon and glatiramer acetate treatment in multiple sclerosis
Multiple Sclerosis,
April 1, 2008;
14(3):
406 - 411.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. L. Minden, D. C. Hoaglin, L. Hadden, D. Frankel, T. Robbins, and J. Perloff
Access to and utilization of neurologists by people with multiple sclerosis
Neurology,
March 25, 2008;
70(13_Part_2):
1141 - 1149.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Cetin, K.L. Johnson, D.M. Ehde, C.M. Kuehn, D. Amtmann, and G.H. Kraft
Antidepressant use in multiple sclerosis: epidemiologic study of a large community sample
Multiple Sclerosis,
September 1, 2007;
13(8):
1046 - 1053.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D C Mohr, S L Hart, L Julian, and E S Tasch
Screening for depression among patients with multiple sclerosis: two questions may be enough
Multiple Sclerosis,
March 1, 2007;
13(2):
215 - 219.
[Abstract]
[PDF]
|
|
|
|
|
|
|
T Kumpfel, L A Hoffmann, W Pollmann, P Rieckmann, U K Zettl, R Kuhnbach, G D Borasio, and R Voltz
Palliative care in patients with severe multiple sclerosis: two case reports and a survey among German MS neurologists
Palliative Medicine,
March 1, 2007;
21(2):
109 - 114.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K Gottberg, U Einarsson, S Fredrikson, L von Koch, and L W Holmqvist
A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence
J. Neurol. Neurosurg. Psychiatry,
January 1, 2007;
78(1):
60 - 65.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. J. Buchanan, R. Schiffer, S. Wang, A. Stuifbergen, B. Chakravorty, L. Zhu, M. Suk Kim, and W. James
Satisfaction With Mental Health Care Among People With Multiple Sclerosis in Urban and Rural Areas
Psychiatr Serv,
August 1, 2006;
57(8):
1206 - 1209.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Schilling, C. Brueckner-Totonji, V. Arolt, and B. T. Baune
A Case of Multiple Sclerosis Masked by Depression and Diabetic Neuropathy
Psychosomatics,
August 1, 2006;
47(4):
361 - 363.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Jefferies
The neuropsychiatry of multiple sclerosis
Adv. Psychiatr. Treat.,
May 1, 2006;
12(3):
214 - 220.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
